158 related articles for article (PubMed ID: 37085701)
21. Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance.
Connor JP; Felder M
Gynecol Oncol; 2008 Nov; 111(2):330-5. PubMed ID: 18723214
[TBL] [Abstract][Full Text] [Related]
22. DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC.
Liu YP; Zhu HF; Liu DL; Hu ZY; Li SN; Kan HP; Wang XY; Li ZG
Oncotarget; 2016 Nov; 7(47):77306-77318. PubMed ID: 27764793
[TBL] [Abstract][Full Text] [Related]
23. Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3.
Im J; Kim K; Hergert P; Nho RS
J Pathol; 2016 Sep; 240(1):25-37. PubMed ID: 27218286
[TBL] [Abstract][Full Text] [Related]
24. Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action.
Yang CR; Hsieh SL; Teng CM; Ho FM; Su WL; Lin WW
Cancer Res; 2004 Feb; 64(3):1122-9. PubMed ID: 14871847
[TBL] [Abstract][Full Text] [Related]
25. Decoy receptor 3 suppresses FasL-induced apoptosis via ERK1/2 activation in pancreatic cancer cells.
Zhang Y; Li D; Zhao X; Song S; Zhang L; Zhu D; Wang Z; Chen X; Zhou J
Biochem Biophys Res Commun; 2015 Aug; 463(4):1144-51. PubMed ID: 26102031
[TBL] [Abstract][Full Text] [Related]
26. Significance of increased expression of decoy receptor 3 in chronic liver disease.
Kim S; Kotoula V; Hytiroglou P; Zardavas D; Zhang L
Dig Liver Dis; 2009 Aug; 41(8):591-8. PubMed ID: 19195939
[TBL] [Abstract][Full Text] [Related]
27. DcR3-TL1A signalling inhibits cytokine-induced proliferation of rheumatoid synovial fibroblasts.
Takahashi M; Miura Y; Hayashi S; Tateishi K; Fukuda K; Kurosaka M
Int J Mol Med; 2011 Sep; 28(3):423-7. PubMed ID: 21537832
[TBL] [Abstract][Full Text] [Related]
28. Expression of death decoy receptor-3 (DcR3) in human breast cancer and its functional effects on breast cancer cells in vitro.
Ge Z; Sanders AJ; Ye L; Wang Y; Jiang WG
J Exp Ther Oncol; 2011; 9(2):109-18. PubMed ID: 21699018
[TBL] [Abstract][Full Text] [Related]
29. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo.
Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D
Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297
[TBL] [Abstract][Full Text] [Related]
30. Crystal Structure of the Complex of Human FasL and Its Decoy Receptor DcR3.
Liu W; Ramagopal U; Cheng H; Bonanno JB; Toro R; Bhosle R; Zhan C; Almo SC
Structure; 2016 Nov; 24(11):2016-2023. PubMed ID: 27806260
[TBL] [Abstract][Full Text] [Related]
31. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer.
Pitti RM; Marsters SA; Lawrence DA; Roy M; Kischkel FC; Dowd P; Huang A; Donahue CJ; Sherwood SW; Baldwin DT; Godowski PJ; Wood WI; Gurney AL; Hillan KJ; Cohen RL; Goddard AD; Botstein D; Ashkenazi A
Nature; 1998 Dec; 396(6712):699-703. PubMed ID: 9872321
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death.
Ibrahim SM; Ringel J; Schmidt C; Ringel B; Müller P; Koczan D; Thiesen HJ; Löhr M
Pancreas; 2001 Jul; 23(1):72-9. PubMed ID: 11451151
[TBL] [Abstract][Full Text] [Related]
33. Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma.
Tsuji S; Hosotani R; Yonehara S; Masui T; Tulachan SS; Nakajima S; Kobayashi H; Koizumi M; Toyoda E; Ito D; Kami K; Mori T; Fujimoto K; Doi R; Imamura M
Int J Cancer; 2003 Aug; 106(1):17-25. PubMed ID: 12794752
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of DcR3 and its significance on tumor cell differentiation and proliferation in glioma.
Huang S; Chen G; Dang Y; Chen LH
ScientificWorldJournal; 2014; 2014():605236. PubMed ID: 24741354
[TBL] [Abstract][Full Text] [Related]
35. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
[TBL] [Abstract][Full Text] [Related]
36. Decoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, Akt-, and NF-kappa B-dependent pathway.
Chen PH; Yang CR
J Immunol; 2008 Dec; 181(12):8441-9. PubMed ID: 19050262
[TBL] [Abstract][Full Text] [Related]
37. Decoy receptor 3 suppresses B cell functions and has a negative correlation with disease activity in rheumatoid arthritis.
Chen MH; Liu PC; Chang CW; Chen YA; Chen MH; Liu CY; Leu CM; Lin HY
Clin Exp Rheumatol; 2014; 32(5):715-23. PubMed ID: 25084482
[TBL] [Abstract][Full Text] [Related]
38. DcR3 protects THP-1 macrophages from apoptosis by increasing integrin alpha4.
Tateishi K; Miura Y; Hayashi S; Takahashi M; Kurosaka M
Biochem Biophys Res Commun; 2009 Nov; 389(4):593-8. PubMed ID: 19748482
[TBL] [Abstract][Full Text] [Related]
39. Sensitization of cells to TRAIL-induced apoptosis by decoy receptor 3.
Wu YY; Chang YC; Hsu TL; Hsieh SL; Lai MZ
J Biol Chem; 2004 Oct; 279(42):44211-8. PubMed ID: 15475369
[TBL] [Abstract][Full Text] [Related]
40. DcR3 induces cell proliferation through MAPK signaling in chondrocytes of osteoarthritis.
Hayashi S; Nishiyama T; Miura Y; Fujishiro T; Kanzaki N; Hashimoto S; Matsumoto T; Kurosaka M; Kuroda R
Osteoarthritis Cartilage; 2011 Jul; 19(7):903-10. PubMed ID: 21420502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
